Connect with us
AstraZeneca’s commitment to the Spanish territory can also be seen in the creation of infrastructure since it has allocated a total of €5.5 million for the...
Each of the clinics that make up IVI RMA's worldwide network (more than 65 clinics) is likely to pursue one or more of the lines of...
Within the pharmaceutical investment in research and development it is necessary to distinguish between different parts of the process. Almost $78 million (€66 million) were allocated...
The biotech sector in Spain is committed to investments in R&D, as the latest report by Asebio showed. More than 70% of the total investments in...
Spain become one of the countries with the best conditions to host the research and development of new medicine. To the point that Spanish doctors and...